Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Drew Moghanaki

Thoracic Rad Onc · UCLA

View

Dr. Himanshu Nagar

GU Rad Onc · MSK

View

Dr. Michael Dykstra

General Rad Onc · UM

View

Dr. Lori Pierce

Breast Rad Onc · UM

View

Dr. William Hwang

GI Rad Onc · MGH

View

Dr. Kamran Ahmed

Breast Rad Onc · Moffitt Cancer Center

View

Dr. James Janopaul-Naylor

GU Rad Onc · MSK

View

Dr. Philip Schauer

Bariatric Surgery · PBRC

View

Dr. Justin Hovey, FAAP, FACP, DABOM

Obesity Medicine · Noland Hospital Dothan II

View

Dr. Kimberly Gudzune

Obesity Medicine · JHU

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms
    RKDr. Ramez Kouzy

    Dr. Ramez Kouzy

    Radiation Oncology · Central Nervous System Cancer Radiation Oncology
    The University of Texas MD Anderson Cancer Center
    ramezk

    Research

    Justification, margin values, and analysis populations for oncologic noninferiority and equivalence trials: a meta-epidemiological study

    2025

    Via Journal of the National Cancer Institute

    Research

    Incomplete Toxicity Reporting and Use of Toxicity-Minimizing Language in Phase III Oncology Trials

    2025

    Via JCO Oncology Practice

    Research

    Survival-Inferred Fragility of Statistical Significance in Phase III Oncology Trials

    2025

    Via medRxiv

    Research

    Safety and early outcomes of proton therapy and low-dose rate brachytherapy boost for patients with prostate cancer

    2025

    Via Brachytherapy

    Research

    Treatment group-specific inferences in Phase III Randomized Oncology Trials

    2025

    Via Acta Oncologica

    Research

    Effect size estimation in cooperative group- and industry-sponsored phase 3 oncology trials

    2025

    Via Journal of the National Cancer Institute

    Research

    Salvage Radiotherapy Following Nonradiotherapy Ablative Techniques for Primary Prostate Cancer: A Systematic Review and Meta-analysis

    2025

    Via European Urology Focus

    Research

    Overall Survival and Quality-of-Life Superiority in Modern Phase 3 Oncology Trials: A Meta-Epidemiological Analysis

    2025

    Via JAMA Oncology

    Research

    Use of natural language processing to identify patients with inflammatory breast cancer across a health-care system

    2025

    Via JNCI Cancer Spectrum

    Research

    Debate 1: High-Risk Localized Prostate Cancer: Why Combination Hormone Therapy and Radiotherapy is the Optimal Treatment Strategy for Most Men

    2025

    Via Seminars in Radiation Oncology

    Research

    Reproducibility of statistically significant phase III oncology trials: An In Silico meta-epidemiological analysis

    2025

    Via European Journal of Cancer

    Research

    Cancer Risk Concerns and Communication Gaps Regarding GLP-1 Medications

    2025

    Via JAMA Network Open

    Research

    Survival-inferred fragility of statistical significance in phase III oncology trials

    2025

    Via NPJ Precision Oncology

    Research

    One shot at trust: building credible evidence for medical artificial intelligence

    2025

    Via The Lancet Digital Health

    Research

    The state of the art in artificial intelligence and digital pathology in prostate cancer

    2025

    Via Nature Reviews Urology